Abliva | BioStock Life Science Summit 2024

(15:5)

Abliva leads the way with potential mitochondrial disease treatment

(12:12)

Abliva | BioStock Global Forum 2024

(15:15)

BioStock Investor Meeting | Abliva | March 2023

(18:36)

BioStock | Abliva | Financing round | June 2022

(6:16)

BioStock Life Science Fall Summit | Abliva | October 2023

(13:37)

BioStock | NLSDays | Abliva

(1:31)

BioStock Life Science Summit 2021 | Abliva

(22:26)

BioStock Live | Abliva March 9 2021

(19:7)

Abliva - Primary Mitochondrial Disease and NAD+/NADH

(3:46)

Elicera Therapeutics | BioStock Life Science Summit 2024

(13:51)

BioStock Life Science Fall Summit | Day 1 Session 1 | October 2023

(1:10:15)

Abliva Patient Interview - MELAS - primary mitochondrial disease

(2:48)

☀️ Causes And Fixes of Mitochondrial Dysfunction!

(55:22)

Bench to Bedside - December 2023: Mitochondrial Disease Clinical Trial Updates

(1:1:48)

BioStock Life Science Summit Nov 17

(5:48:14)

BioStock Investor Pitch| Toleranzia | September 2023

(24:49)

Abliva – What is mitochondrial disease?

(1:36)

ABLIVA – Kvinnokvällen Göteborg 12 oktober 2020

(30:16)

BioStock | Abliva on the phase II-study | March 2023

(5:40)

Abliva | BioStock Life Science Summit 2020

(16:19)

Abliva - About Lead Candidate KL1333

(2:16)

Abliva - Living with Mitochondrial Disease - World Mitochondrial Disease Week 2022

(4:55)

Abliva - Introducing the FALCON study - World Mitochondrial Disease Week

(2:31)

Abliva - Developing the PROMIS Fatigue Mitochondrial Disease Short Form

(2:42)

Abliva - Introducing Mitochondrial “Mito” Disease - World Mitochondrial Disease Week 2022

(2:32)

Abliva - A Patient-Centric Approach to Drug Development - World Mitochondrial Disease Week 2022

(3:47)

Abliva participates in World Mitochondrial Disease Week 2023

(1:8)

Abliva - Participating in the FALCON Study - World Mitochondrial Disease Week 2023

(2:20)

Abliva - CEO Ellen Donnelly talks about the positive interim analysis in the FALCON study

(3:24)